1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA HIST1H3B CTRPv2 pan-cancer AAC -0.09 0.01
mRNA VGF CTRPv2 pan-cancer AAC 0.09 0.01
mRNA PFDN4 CTRPv2 pan-cancer AAC -0.09 0.01
mRNA AC026348.1 CTRPv2 pan-cancer AAC 0.092 0.01
mRNA LIMK2 CTRPv2 pan-cancer AAC 0.095 0.01
mRNA ZNF821 CTRPv2 pan-cancer AAC -0.098 0.01
mRNA C14orf79 CTRPv2 pan-cancer AAC 0.1 0.01
mRNA RRAGC CTRPv2 pan-cancer AAC -0.092 0.01
mRNA NANOGP8 CTRPv2 pan-cancer AAC 0.089 0.01
mRNA LRP1 CTRPv2 pan-cancer AAC -0.1 0.01
Download CSV